Find Arsenic Trioxide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0INTERMEDIATES

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

233 RELATED EXCIPIENT COMPANIES

419EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Ncgc00356590-01, Sr-01000942221, Sr-01000942221-2
Molecular Formula
As2O3
Molecular Weight
197.841  g/mol
InChI Key
GOLCXWYRSKYTSP-UHFFFAOYSA-N

Arsenic Trioxide
1 2D Structure

Arsenic Trioxide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2,4,5-trioxa-1,3-diarsabicyclo[1.1.1]pentane
2.1.2 InChI
InChI=1S/As2O3/c3-1-4-2(3)5-1
2.1.3 InChI Key
GOLCXWYRSKYTSP-UHFFFAOYSA-N
2.1.4 Canonical SMILES
O1[As]2O[As]1O2
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. Ncgc00356590-01

2. Sr-01000942221

3. Sr-01000942221-2

2.3 Create Date
2005-03-27
3 Chemical and Physical Properties
Molecular Weight 197.841 g/mol
Molecular Formula As2O3
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count0
Exact Mass197.82793 g/mol
Monoisotopic Mass197.82793 g/mol
Topological Polar Surface Area27.7 Ų
Heavy Atom Count5
Formal Charge0
Complexity33.4
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Flag U.S.A
Digital Content Digital Content

Arsenic Trioxide

About the Company : Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs ...

Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs to regulated markets worldwide and has exclusive partnerships for new product development, compliance support and secure supply chain logistics. ChemWerth has access to over 500 APIs and more than 30 manufacturing facilities in the US, Europe, India and China. ChemWerth acts as a regulatory agent for over 25 FDA-approved facilities and sells more than 100 products. It has established its presence in 38 countries. In 2020, ChemWerth filed its 500th DMF with the FDA.
Chemwerth Compnay Banner

02

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

Arsenic Trioxide

About the Company : Emcure Pharmaceuticals Ltd. is a fast-growing fully integrated Indian pharmaceutical company with a global presence engaged in developing, manufacturing, and marketing a broad rang...

Emcure Pharmaceuticals Ltd. is a fast-growing fully integrated Indian pharmaceutical company with a global presence engaged in developing, manufacturing, and marketing a broad range of pharmaceutical products. Its core strength lies in developing and manufacturing differentiated pharmaceutical products in-house, which it commercializes across geographies. Emcure has launched 6 biosimilars in the Domestic Market & RoW markets & Its subsidiary - Gennova is leading the creation of India’s first indigenous mRNA vaccine to combat COVID- 19 which is currently under trial.
blank

03

Heraeus Holding

Germany
Antibody Engineering
Not Confirmed
arrow

Heraeus Holding

Germany
arrow
Antibody Engineering
Not Confirmed

Arsenic Trioxide

About the Company : Heraeus Precious Metals business line Pharmaceutical Ingredients is specialized in the production of generic APIs as well as the exclusive synthesis of cytotoxic compounds from the...

Heraeus Precious Metals business line Pharmaceutical Ingredients is specialized in the production of generic APIs as well as the exclusive synthesis of cytotoxic compounds from the research stage to registration to market launch. All Pt hAPIs are developed and manufactured at Heraeus’ headquarters in Hanau, Germany. For more than 30 years,it has been building its reputation as number one supplier of Pt hAPIs used in cancer therapies worldwide. By putting great emphasis on the highest quality of all its products, Heraeus Pharmaceutical takes pride of being certified by all major health authorities & agencies, including USFDA.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - INJECTABLE;INJECTION - 1MG/ML **Fede...DOSAGE - INJECTABLE;INJECTION - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21248

read-more

DOSAGE - INJECTABLE;INJECTION - 2MG/ML

USFDA APPLICATION NUMBER - 21248

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Topical

read-more
read-more

Parenteral

read-more
read-more

Solubilizers

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Taste Masking

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Lubricants & Glidants

read-more
read-more

Granulation

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Coating Systems & Additives

read-more
read-more

Emulsifying Agents

read-more
read-more

Controlled & Modified Release

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

API Stability Enhancers

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Exclusivities

read-more
read-more

01

arrow
Antibody Engineering
Not Confirmed

CEPHALON

U.S.A
arrow
Antibody Engineering
Not Confirmed

ARSENIC TRIOXIDE

Exclusivity Code : ODE-167

Exclusivity Expiration Date : 2025-01-12

Application Number : 21248

Product Number : 1

Exclusivity Details :

blank

02

arrow
Antibody Engineering
Not Confirmed

CEPHALON

U.S.A
arrow
Antibody Engineering
Not Confirmed

ARSENIC TRIOXIDE

Exclusivity Code : ODE-167

Exclusivity Expiration Date : 2025-01-12

Application Number : 21248

Product Number : 2

Exclusivity Details :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty